Keros Therapeutics Inc

NASDAQ:KROS   3:17:42 PM EDT
48.25
+0.26 (+0.54%)
Products, Strategic Combinations

Keros Therapeutics Announces Licensing Agreement And Strategic Partnership With Hansoh Pharma

Published: 12/13/2021 13:10 GMT
Keros Therapeutics Inc (KROS) - Keros Therapeutics Announces Licensing Agreement and Strategic Partnership With Hansoh Pharma for Rights to Ker-050 in China.
Keros Therapeutics Inc - Keros Therapeutics to Receive Potential Milestone Payments Up to $170.5 Million.
Keros Therapeutics Inc - Hansoh Will Obtain an Exclusive License From Keros to Develop, Manufacture and Commercialize Ker-05.